Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Loperamide for prevention of high-output ileostomy
ACTRN12614000180617Phase 3Terminated
- Sponsor
- Hunter New England Local Health District
- Start
- Aug 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of loperamide in ileostomy (2 arms), sponsored by Hunter New England Local Health District. Primary endpoint: Incidence of high output ileostomy. Started Aug 2014; status: terminated.
02
Drugs
loperamide
03
Conditions
ileostomy
Beyond the preview
Go deeper on ACTRN12614000180617.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000180617.